Angioline to expand medical device production in Novosibirsk

Angioline will build a new 8,500 sq m facility in Koltsovo Biotechnopark for coronary stents and catheters, with investment of 500 million RUB and 250 new jobs. Construction runs 2017-2019, commissioning in 2020.

“Общая площадь нового здания должна составить 8,5 тыс. кв. м.”meditex.ru

• 1 source
• meditex.ruНовостиMay 26, 2017

Summarized from public sources; check the original articles before acting on it.